Establishment of functional analysis for genes involved in NK cell tumors using normal NK cell expansion method
使用正常 NK 细胞扩增方法建立 NK 细胞肿瘤相关基因的功能分析
基本信息
- 批准号:23659194
- 负责人:
- 金额:$ 2.5万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Challenging Exploratory Research
- 财政年份:2011
- 资助国家:日本
- 起止时间:2011 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In an attempt to clarify molecular mechanisms of NK cell tumor development, oligo-array CGH and expression profiling were applied. Oligo-array CGH identified two distinct minimal common deleted regions at 6q21 where the most frequent deletion was observed at the percentage of 36%(14 of 39 cases). The genes identified were PRDM1 and FOXO3 which were functionally approved by inducing expression system. Normal NK cells were know to be expanded by culturing peripheral blood mononuclear cells(PBMC) with irradiated K562-mb15-41BBL cells to one million order of magnitude. We could amplified normal NK cells to the same order of magnitude with feeder cells recovered from frozen status. This system will be useful for the functional analysis of genes involved in NK cell tumor development.
为了阐明 NK 细胞肿瘤发展的分子机制,应用了寡阵列 CGH 和表达谱。寡阵列 CGH 在 6q21 处识别出两个不同的最小常见缺失区域,其中观察到最频繁缺失的百分比为 36%(39 例中的 14 例)。鉴定出的基因是PRDM1和FOXO3,它们通过诱导表达系统得到功能认可。众所周知,通过将外周血单核细胞 (PBMC) 与受辐射的 K562-mb15-41BBL 细胞一起培养,可以将正常 NK 细胞扩增至一百万数量级。我们可以将正常 NK 细胞扩增至与从冷冻状态恢复的饲养细胞相同的数量级。该系统可用于 NK 细胞肿瘤发展相关基因的功能分析。
项目成果
期刊论文数量(53)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Promotion and maintenance of leukemia by ERG
- DOI:10.1182/blood-2010-11-320515
- 发表时间:2011-04-07
- 期刊:
- 影响因子:20.3
- 作者:Tsuzuki, Shinobu;Taguchi, Osamu;Seto, Masao
- 通讯作者:Seto, Masao
Gene Expression Profiling of Age-Related Epstein-Barr Virus(EBV)-Associated B-Cell Lymphoproliferative Disorder Uncovers Alterations in Immune andInflammatory Genes : Possible Implications for Pathogenesis
年龄相关的 Epstein-Barr 病毒 (EBV) 相关 B 细胞淋巴细胞增殖性疾病的基因表达谱揭示了免疫和炎症基因的改变:对发病机制的可能影响
- DOI:
- 发表时间:2011
- 期刊:
- 影响因子:0
- 作者:Harumi Kato;Kazuhito Yamamoto;Masao Seto
- 通讯作者:Masao Seto
Expansion of functionally defined mouse hematopoietic stem/progenitor cells by a short isoform of RUNX1/AML1
通过 RUNX1/AML1 的短亚型扩增功能明确的小鼠造血干/祖细胞
- DOI:
- 发表时间:2012
- 期刊:
- 影响因子:20.3
- 作者:Tsuzuki S;Seto M.
- 通讯作者:Seto M.
International Peripheral T-cell Lymphoma Project. Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic・χT-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro
国际外周T细胞淋巴瘤项目。自然杀伤细胞淋巴瘤与一组非肝脾·χT细胞淋巴瘤具有惊人相似的分子特征,并且在体外对新型极光激酶A抑制剂高度敏感。
- DOI:
- 发表时间:2011
- 期刊:
- 影响因子:11.4
- 作者:Iqbal J;Weisenburger DD;Seto M
- 通讯作者:Seto M
Identification of FOXO3 and PRDM1 as tumor suppressor gene candidates in NK cell neoplasms by the combination of genomic and functional analyses
通过基因组和功能分析相结合,鉴定 FOXO3 和 PRDM1 作为 NK 细胞肿瘤中的候选抑癌基因
- DOI:
- 发表时间:2011
- 期刊:
- 影响因子:0
- 作者:Kennosuke Karube;Masao Nakagawa;Masao Seto
- 通讯作者:Masao Seto
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SETO Masao其他文献
SETO Masao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SETO Masao', 18)}}的其他基金
Lymphomagenesis pathway consisting of various cooperative genes and their relevance as molecular target therapy
由各种协同基因组成的淋巴瘤发生途径及其作为分子靶向治疗的相关性
- 批准号:
24390249 - 财政年份:2012
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Biologic significance of candidate genes in genomic alteration regions of lymphoidmalignancies
淋巴恶性肿瘤基因组改变区域候选基因的生物学意义
- 批准号:
20390277 - 财政年份:2008
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Biological role of genes at genetic alteration regions for proliferation and differentiation in hem
基因改变区域基因对下摆增殖和分化的生物学作用
- 批准号:
18390286 - 财政年份:2006
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular mechanisms of lymphomagenesis
淋巴瘤发生的分子机制
- 批准号:
17015050 - 财政年份:2005
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Genomic alteration in hematologic malignancies and their roles for proliferation and differentiation
血液恶性肿瘤中的基因组改变及其对增殖和分化的作用
- 批准号:
16390282 - 财政年份:2004
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Roles of translocation junction genes for proliferation and differentiation of hemotolymphoid cell
易位连接基因对血淋巴细胞增殖和分化的作用
- 批准号:
14370312 - 财政年份:2002
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Chromosome translocation junction genes on lympho-hematopoietic cell proliferation and differentiation
染色体易位连接基因对淋巴造血细胞增殖和分化的影响
- 批准号:
11470215 - 财政年份:1999
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
BIOLOGICAL ROLE OF CHROMOSOME TRANSLOCATION JUNCTION REGION GENES IN HEMATOPOIETIC CELL DIFFERENTIATION AND PROLIFERATION
染色体易位连接区基因在造血细胞分化和增殖中的生物学作用
- 批准号:
08457282 - 财政年份:1996
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Development pf novel immune checkpoint inhibition therapy for neuroblastoma focusing on the tumor infiltrating immune cells
开发针对神经母细胞瘤的新型免疫检查点抑制疗法,重点关注肿瘤浸润免疫细胞
- 批准号:
21K08626 - 财政年份:2021
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetic alterations of aggressive NK cell leukemia and identification of molecular target candidates
侵袭性 NK 细胞白血病的基因改变和候选分子靶标的鉴定
- 批准号:
15K09471 - 财政年份:2015
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of therapeutic mAbs for malignant lymphoma
恶性淋巴瘤治疗性单克隆抗体的建立
- 批准号:
15K06880 - 财政年份:2015
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Combinatorial Immunotherapy of poly-IC and anti-PD-L1 antibody for head and neck malignancies
聚 IC 和抗 PD-L1 抗体联合免疫疗法治疗头颈恶性肿瘤
- 批准号:
15K20172 - 财政年份:2015
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Examination of the molecular target treatment for CD70 in the nasal NK/T cell lymphoma
鼻腔NK/T细胞淋巴瘤CD70分子靶向治疗研究
- 批准号:
26462576 - 财政年份:2014
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)